Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A
Public ClinicalTrials.gov record NCT01178294. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies
Study identification
- NCT ID
- NCT01178294
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Baxalta now part of Shire
- Industry
- Enrollment
- 29 participants
Conditions and interventions
Conditions
Interventions
- OBI-1 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 9, 2010
- Primary completion
- Jun 30, 2013
- Completion
- Oct 8, 2013
- Last update posted
- May 12, 2021
2010 – 2013
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana Hemophilia and Thrombosis Center | Indianapolis | Indiana | 46260 | — |
| Louisiana Center for Bleeding & Clotting Disorders | New Orleans | Louisiana | 70112-2699 | — |
| National Institutes of Health - Warren G. Magnuson Clinical Center | Bethesda | Maryland | 20892-1508 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| University of North Carolina at Chapel Hill Hospital | Chapel Hill | North Carolina | 27599-7305 | — |
| The Pennsylvania State University and Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Vanderbilt University Medical Center, Hemostasis/Hemophilia Clinic | Nashville | Tennessee | 37232-9830 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01178294, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01178294 live on ClinicalTrials.gov.